tradingkey.logo

Akoustis Technologies Ord Shs

AKTS
查看详细走势图
18.980USD
-0.590-3.01%
收盘 02/06, 16:00美东报价延迟15分钟
2.93B总市值
亏损市盈率 TTM

Akoustis Technologies Ord Shs

18.980
-0.590-3.01%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.01%

5天

-6.27%

1月

0.00%

6月

0.00%

今年开始到现在

0.00%

1年

0.00%

查看详细走势图

TradingKey股票评分

由于缺少必要的数据,暂不能对该公司进行评分

Akoustis Technologies Ord Shs新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Akoustis Technologies Ord Shs简介

Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
公司代码AKTS
公司Akoustis Technologies Ord Shs
CEORoden (Matthew)
网址https://www.aktisoncology.com/
KeyAI